Literature DB >> 18843656

Exercise for depression.

Gillian E Mead1, Wendy Morley, Paul Campbell, Carolyn A Greig, Marion McMurdo, Debbie A Lawlor.   

Abstract

BACKGROUND: Depression is a common and important cause of morbidity and mortality worldwide. Depression is commonly treated with antidepressants and/or psychotherapy, but some people may prefer alternative approaches such as exercise. There are a number of theoretical reasons why exercise may improve depression.
OBJECTIVES: To determine the effectiveness of exercise in the treatment of depression. SEARCH STRATEGY: We searched Medline, Embase, Sports Discus, PsycLIT, the Cochrane Controlled Trials Register, and the Cochrane Database of Systematic Reviews for eligible studies. In addition, we hand-searched several relevant journals, contacted experts in the field, searched bibliographies of retrieved articles, and performed citation searches of identified studies. We also searched www.controlled-trials.com. SELECTION CRITERIA: Randomised controlled trials in which exercise was compared to standard treatment, no treatment or a placebo treatment in adults (aged 18 and over) with depression, as defined by trial authors. We excluded trials of post-natal depression. DATA COLLECTION AND ANALYSIS: We calculated effect sizes for each trial using Cohen's method and a standardised mean difference (SMD) for the overall pooled effect, using a random effects model. Where trials used a number of different tools to assess depression, we included the main outcome measure only in the meta-analysis. MAIN
RESULTS: Twenty-eight trials fulfilled our inclusion criteria, of which 25 provided data for meta-analyses. Randomisation was adequately concealed in a minority of studies, most did not use intention to treat analyses and most used self-reported symptoms as outcome measures. For the 23 trials (907 participants) comparing exercise with no treatment or a control intervention, the pooled SMD was -0.82 (95% CI -1.12, -0.51), indicating a large clinical effect. However, when we included only the three trials with adequate allocation concealment and intention to treat analysis and blinded outcome assessment, the pooled SMD was -0.42 (95% CI -0.88, 0.03) i.e. moderate, non-significant effect. The effect of exercise was not significantly different from that of cognitive therapy. There was insufficient data to determine risks and costs. AUTHORS'
CONCLUSIONS: Exercise seems to improve depressive symptoms in people with a diagnosis of depression, but when only methodologically robust trials are included, the effect sizes are only moderate and not statistically significant. Further, more methodologically robust trials should be performed to obtain more accurate estimates of effect sizes, and to determine risks and costs. Further systematic reviews could be performed to investigate the effect of exercise in people with dysthymia who do not fulfil diagnostic criteria for depression.

Entities:  

Mesh:

Year:  2008        PMID: 18843656     DOI: 10.1002/14651858.CD004366.pub3

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  40 in total

1.  Specific medical conditions associated with clinically significant depressive symptoms in men.

Authors:  Evan Atlantis; Kylie Lange; Robert D Goldney; Sean Martin; Matthew T Haren; Anne Taylor; Peter D O'Loughlin; Villis Marshall; Wayne Tilley; Gary A Wittert
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-10-26       Impact factor: 4.328

Review 2.  Elucidating opportunities and pitfalls in the treatment of experimental traumatic brain injury to optimize and facilitate clinical translation.

Authors:  Patricia B de la Tremblaye; Darik A O'Neil; Megan J LaPorte; Jeffrey P Cheng; Joshua A Beitchman; Theresa Currier Thomas; Corina O Bondi; Anthony E Kline
Journal:  Neurosci Biobehav Rev       Date:  2017-05-30       Impact factor: 8.989

3.  Feasibility of Behavioral Weight Loss Treatment Enhanced with Peer Support and Mobile Health Technology for Individuals with Serious Mental Illness.

Authors:  Kelly A Aschbrenner; John A Naslund; Megan Shevenell; Kim T Mueser; Stephen J Bartels
Journal:  Psychiatr Q       Date:  2016-09

Review 4.  Influence of physical exercise on traumatic brain injury deficits: scaffolding effect.

Authors:  Trevor Archer
Journal:  Neurotox Res       Date:  2011-12-20       Impact factor: 3.911

5.  Associations between Depression and Health Behaviour Change: Findings from 8 Cycles of the Canadian Community Health Survey.

Authors:  Zahra M Clayborne; Ian Colman
Journal:  Can J Psychiatry       Date:  2018-05-07       Impact factor: 4.356

Review 6.  Tai Chi and Qigong for the treatment and prevention of mental disorders.

Authors:  Ryan Abbott; Helen Lavretsky
Journal:  Psychiatr Clin North Am       Date:  2013-03

7.  What is the benefit of a high-intensive exercise program on health-related quality of life and depression after stroke? A randomized controlled trial.

Authors:  Eva Holmgren; Gunilla Gosman-Hedström; Britta Lindström; Per Wester
Journal:  Adv Physiother       Date:  2010-06-14

8.  Association between common mental disorder and obesity over the adult life course.

Authors:  Mika Kivimäki; G David Batty; Archana Singh-Manoux; Hermann Nabi; Séverine Sabia; Adam G Tabak; Tasnime N Akbaraly; Jussi Vahtera; Michael G Marmot; Markus Jokela
Journal:  Br J Psychiatry       Date:  2009-08       Impact factor: 9.319

9.  A pilot trial of a videogame-based exercise program for methadone maintained patients.

Authors:  Christopher J Cutter; Richard S Schottenfeld; Brent A Moore; Samuel A Ball; Mark Beitel; Jonathan D Savant; Matthew A Stults-Kolehmainen; Christopher Doucette; Declan T Barry
Journal:  J Subst Abuse Treat       Date:  2014-06-10

10.  Common mental disorder and obesity: insight from four repeat measures over 19 years: prospective Whitehall II cohort study.

Authors:  Mika Kivimäki; Debbie A Lawlor; Archana Singh-Manoux; G David Batty; Jane E Ferrie; Martin J Shipley; Hermann Nabi; Séverine Sabia; Michael G Marmot; Markus Jokela
Journal:  BMJ       Date:  2009-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.